Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Brief Summary: The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.


Options:
A: Arm Label: Valsartan 160 mg + nateglinide 60 mg; Type: EXPERIMENTAL; Interventions: Drug: Valsartan 160 mg + nateglinide 60 mg | Arm Label: Valsartan 160 mg + nateglinide placebo; Type: EXPERIMENTAL; Interventions: Drug: Valsartan 160 mg + nateglinide placebo | Arm Label: Nateglinide 60 mg + valsartan placebo; Type: EXPERIMENTAL; Interventions: Drug: Nateglinide 60 mg + valsartan placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Valsartan placebo + nateglinide placebo | Intervention Type: DRUG; Name: Valsartan 160 mg + nateglinide 60 mg; Assigned to Arm(s): Valsartan 160 mg + nateglinide 60 mg | Intervention Type: DRUG; Name: Valsartan 160 mg + nateglinide placebo; Assigned to Arm(s): Valsartan 160 mg + nateglinide placebo | Intervention Type: DRUG; Name: Nateglinide 60 mg + valsartan placebo; Assigned to Arm(s): Nateglinide 60 mg + valsartan placebo | Intervention Type: DRUG; Name: Valsartan placebo + nateglinide placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Rosiglitazone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: glyburide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): N/A
C: Arm Label: 1 Original Lifestyle; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Behavioral: DPPOS Boost Lifestyle, Behavioral: Intensive Lifestyle Group Session | Arm Label: 2 Original Metformin; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Drug: Metformin, Behavioral: Intensive Lifestyle Group Session | Arm Label: 3 Original Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Behavioral: Intensive Lifestyle Group Session | Intervention Type: BEHAVIORAL; Name: DPPOS Group Lifestyle; Assigned to Arm(s): 1 Original Lifestyle, 2 Original Metformin, 3 Original Placebo | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 2 Original Metformin | Intervention Type: BEHAVIORAL; Name: DPPOS Boost Lifestyle; Assigned to Arm(s): 1 Original Lifestyle | Intervention Type: BEHAVIORAL; Name: Intensive Lifestyle Group Session; Assigned to Arm(s): 1 Original Lifestyle, 2 Original Metformin, 3 Original Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Pioglitazone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pioglitazone | Intervention Type: DRUG; Name: Pioglitazone; Assigned to Arm(s): Pioglitazone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B